Simple Summary There are currently no blood biomarkers approved for routine clinical use
in endometrial cancer. Serum human epididymis protein 4 (HE4) is significantly higher in …

Simple Summary Ovarian cancer is the most common cause of death from gynaecological
cancer in the UK. Survival is better when the disease is diagnosed early. However …

Gynecologic cancers are the leading cause of death in women. Endometrial, ovarian, and
cervical cancer are the three main types of gynecologic cancers. Poor prognoses and high …

Simple Summary Early diagnosis of ovarian cancer is challenging due to vague symptoms
and a lack of screening tools. We aimed to evaluate two simple, non-invasive urine …

Simple Summary Women with suspected endometrial cancer undergo investigations that
can be painful and anxiety-provoking. These tests are avoidable, as only 5–10% of …

Early detection of endometrial cancer improves survival. Non-invasive diagnostic
biomarkers would improve triage of symptomatic women for investigations. This study aimed …

Background Several diagnostic prediction models to help clinicians discriminate between
benign and malignant adnexal masses are available. This study is a head-to-head …

Human epididymal secretory protein 4 (HE4) elevation has been studied as a crucial
biomarker for malignant gynecological cancer, such us ovarian cancer (OC). However, there …

Background: We compared the performance of 21 different assays performed by the Wantai
Wan200+ (Wantai BioPharm, Beijing, China) with respect to other methods in use at the …

Trypanosoma evansi is a blood parasite responsible for surra in mammals, with a high
impact in camels and horses. The WOAH-recommended reference method for detecting …